BWV Blue Water Vaccines, Inc. Stock Quote

BWV [NASD]

Index	-	P/E	-	EPS (ttm)	-0.37	Insider Own	27.50%	Shs Outstand	12.25M	Perf Week	-0.72%
Market Cap	50.59M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	4.83M	Perf Month	12.84%
Income	-4.00M	PEG	-	EPS next Q	-	Inst Own	10.90%	Short Float	11.43%	Perf Quarter	-91.67%
Sales	-	P/S	-	EPS this Y	-87.30%	Inst Trans	-	Short Ratio	0.17	Perf Half Y	-
Book/sh	-	P/B	-	EPS next Y	-	ROA	-	Target Price	-	Perf Year	-
Cash/sh	0.16	P/C	26.63	EPS next 5Y	-	ROE	-	52W Range	3.26 - 90.90	Perf YTD	-92.80%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-95.46%	Beta	-
Dividend %	-	Quick Ratio	1.90	Sales past 5Y	-	Gross Margin	-	52W Low	26.69%	ATR	0.97
Employees	5	Current Ratio	1.90	Sales Q/Q	-	Oper. Margin	-	RSI (14)	33.44	Volatility	10.49% 30.39%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	-187.80%	Profit Margin	-	Rel Volume	0.14	Prev Close	4.35
Shortable	No	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	3.27M	Price	4.13
Recom	-	SMA20	-11.22%	SMA50	-78.64%	SMA200	-85.90%	Volume	463,749	Change	-5.06%

May-19-22 02:00PM	Blue Water Vaccines Announces Collaboration with Instituto Butantan for the Development of BWV-101, a Universal Influenza Vaccine Candidate GlobeNewswire -6.45%
May-13-22 05:01PM	Blue Water Vaccines Reports First Quarter 2022 Financial Results and Recent Business Developments GlobeNewswire -15.65%
May-12-22 08:30AM	Blue Water Vaccines Inc. to Present at H.C. Wainwright Global Investment Conference GlobeNewswire +11.65%
May-11-22 01:00PM	Blue Water Vaccines Announces Expanded License Agreement with St. Jude Childrens Research Hospital for Novel Bacterial Vaccine Platform GlobeNewswire +18.54%
Apr-27-22 12:30PM	Tenon Medical, Ostin Technology Shares Rocket in Market Debuts Barrons.com
12:30PM	Tenon Medical, Ostin Technology Shares Rocket Higher in Market Debuts Barrons.com
Apr-21-22 08:45AM	Blue Water Vaccines Presents New Data Supporting Universal Influenza Vaccine Candidate at the World Vaccine Congress 2022 in Washington, DC GlobeNewswire -11.40%
Apr-20-22 09:25AM	Blue Water Vaccines Announces Closing of $8 Million Private Placement Priced At-the-Market Under Nasdaq Rules GlobeNewswire -6.56%
Apr-13-22 09:30AM	Blue Water Vaccines Announces $8 Million Private Placement Priced At-the-Market Under Nasdaq Rules GlobeNewswire -7.07%
Apr-11-22 09:56AM	Blue Water Vaccines Inc to Present at World Vaccine Congress Washington 2022 GlobeNewswire -25.81%
Apr-08-22 09:44AM	BioMed Leaders: Sunshine Biopharma, PharmaDrug, Blue Water Vaccines, and MedAvail; Visionary CEOs Advancing Healthcare, with Vaccines, Cancer Therapeutics, and Affordable Pharmaceuticals GlobeNewswire +6.69%
Apr-01-22 05:04PM	IPOs Had a Dismal Quarter. The Silent Spell Could Be Ending. Barrons.com +9.59%
Mar-22-22 07:00AM	Blue Water Vaccines Announces Publication in Nano Research Supporting Novel S&P Vaccine Platform Versatility GlobeNewswire +10.67%
Feb-23-22 04:51PM	Blue Water Vaccines Announces Closing of Initial Public Offering GlobeNewswire -12.59%

Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. The company was incorporated in 2018 and is based in Cincinnati, Ohio.

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience